M/L Taper with Kinectiv Technology Prosthesis by Zimmer: Class I Recall - Higher than Expected Levels of Manufacturing Residues
Can cause serious adverse health issues including allergic reactions, pain, infections, or death.
Can cause serious adverse health issues including allergic reactions, pain, infections, or death.
The bulletin “Focus Farmacovigilanza” has always been particularly sensitive to the conflict of interest issue, to the point of reporting to the reader even the possible conflicts concerning the sources used in the various articles. It’s worth reminding that “Focus Farmacovigilanza” is not a journal that publishes original research articles or reviews, but a bulletin that disseminates news and comments in the field of pharmacovigilance. It is therefore a tertiary literature journal aiming to disseminate medical-scientific information.
An interruption in electrical connection would cause the pump to stop, which could cause serious patient injury or death.
Health care professionals should continue to follow the recommendations provided in the BOXED WARNING, FDA’s most serious type of warning, and the WARNINGS AND PRECAUTIONS and INDICATIONS AND USAGE sections of the labeling.
L'Agenzia Italiana del Farmaco rende disponibili nuove e importanti informazioni di sicurezza su Ketoconazole HRA, autorizzato per il trattamento della sindrome di Cushing endogena in adulti e adolescenti sopra i 12 anni di età.
L'Agenzia europea per i medicinali (EMA) ha avviato una revisione di 
canagliflozin, dapagliflozin e empagliflozin, medicinali noti come 
inibitori del SGLT2, usati nel trattamento del diabete di tipo 2.
L'Agenzia Italiana del Farmaco rende disponibili nuove e importanti informazioni su Kineret (anakinra), 100 mg e 100 mg/0,67 ml soluzione iniettabile in siringa preriempita.
80.211.154.110